{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:22:47Z","timestamp":1781889767160,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Melanomas of the female gynecological tract comprise approximately 18% of mucosal melanomas, a rare subtype of melanoma. Within the female genital tract, 70% of primary melanomas of the gynecological tract are from the vulva with the remainder occurring in the vagina and rarely, in the cervix. We investigate molecular alterations by next-generation sequencing-based molecular tests targeting 99 cancer genes and translocation\/fusion assays in 4 and 3 vaginal melanomas, respectively. The ages of the 4 patients range from 65 to 90 years. Postmenopausal bleeding was the most common presenting symptom. Tumor size ranged from 0.5 to 6.6 cm. <jats:italic toggle=\"yes\">KIT<\/jats:italic> L576P mutation was documented in case 1, whereas <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutation was seen in cases 2 and 3 (L130F and Y163C). Case 2 also harbored <jats:italic toggle=\"yes\">NF2<\/jats:italic> E204Q and <jats:italic toggle=\"yes\">ATRX<\/jats:italic> D1719H mutations. A number of gene copy alterations were noted in case 4, which included <jats:italic toggle=\"yes\">GNA11<\/jats:italic> loss, <jats:italic toggle=\"yes\">MYC<\/jats:italic> gain, <jats:italic toggle=\"yes\">RET<\/jats:italic> loss, <jats:italic toggle=\"yes\">SMO<\/jats:italic> loss, <jats:italic toggle=\"yes\">SUFU<\/jats:italic> loss, and <jats:italic toggle=\"yes\">TSC2<\/jats:italic> loss. No gene fusion was detected in any of the 3 tested cases. In conclusion, in addition to <jats:italic toggle=\"yes\">KIT<\/jats:italic>, <jats:italic toggle=\"yes\">TP53<\/jats:italic>, and <jats:italic toggle=\"yes\">ATRX<\/jats:italic> mutations, which have been previously reported, our cases harbor <jats:italic toggle=\"yes\">NF2<\/jats:italic> mutation and multiple gene copy alterations that have not previously been documented in vaginal melanomas. These findings highlight the potential role of targeted therapy in this rare melanoma subtype.<\/jats:p>","DOI":"10.1097\/dad.0000000000001759","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T01:02:17Z","timestamp":1596330137000},"page":"45-48","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Molecular Alterations in Vaginal Melanomas: Report of 4 Cases and Literature Review"],"prefix":"10.1097","volume":"43","author":[{"given":"Jakob M. T.","family":"Moran","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyoto University Hospital, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Iwahashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Cornejo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American college of surgeons commission on cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2018.04.562","article-title":"Melanoma of the lower genital tract: prognostic factors and treatment modalities","volume":"150","author":"Gadducci","year":"2018","journal-title":"Gynecol Oncol."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0002-9378(94)90137-6","article-title":"Malignant melanoma of the vulva and vagina in the United States: patterns of incidence of population-based estimates of survival","volume":"171","author":"Weinstock","year":"1994","journal-title":"Am J Obstet Gynecol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6","article-title":"The national cancer data base report on cancer of the vagina","volume":"83","author":"Creasman","year":"1998","journal-title":"Cancer."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/1078-0432.CCR-03-0562","article-title":"Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jcp.2004.022509","article-title":"BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs","volume":"58","author":"Wong","year":"2005","journal-title":"J Clin Pathol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin Cancer Res."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.gyobfe.2011.11.005","article-title":"Malignant melanoma of the vagina: pejorative location","volume":"40","author":"Gauthier","year":"2012","journal-title":"Gynecol Obstet Fertil."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2014.04.056","article-title":"NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract\u2014a study of 24 cases from The Netherlands","volume":"134","author":"Van Engen-Van Grunsven","year":"2014","journal-title":"Gynecol Oncol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/modpathol.2013.211","article-title":"Comparison of molecular abnormalities in vulvar and vaginal melanomas","volume":"27","author":"Aulmann","year":"2014","journal-title":"Mod Pathol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaad.2014.03.033","article-title":"Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract","volume":"71","author":"Tseng","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/LGT.0000000000000142","article-title":"Malignant melanoma of vulva and vagina: a histomorphological review and mutation analysis- a single-center study","volume":"19","author":"Rouzbahman","year":"2015","journal-title":"J Low Genit Tract Dis."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cncr.30473","article-title":"Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma","volume":"123","author":"Hou","year":"2017","journal-title":"Cancer."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/CMR.0000000000000480","article-title":"Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation: a single-institution experience","volume":"28","author":"Saglam","year":"2018","journal-title":"Melanoma Res."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1634\/theoncologist.2019-0148","article-title":"Prevalence of NRAS mutation, PD-L1 expression and amplification, and overall survival analysis in 36 primary vaginal melanomas","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist."},{"key":"R17-20250616","article-title":"Mutational profile in vulvar, vaginal, and urethral melanomas: review of 37 cases with focus on primary tumor site","author":"Zarei","year":"2019","journal-title":"Int J Gynecol Pathol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41379-019-0345-2","article-title":"Predictive biomarkers and tumor microenvironment in female genital melanomas: a multi-institutional study of 55 cases","volume":"33","author":"Yu","year":"2020","journal-title":"Mod Pathol."},{"key":"R19-20250616","article-title":"Distinct genomic features in a retrospective cohort of mucosal, acral and vulvovaginal melanomas","author":"Shi","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pcmr.12129","article-title":"Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral\/mucosal melanomas","volume":"26","author":"Niu","year":"2013","journal-title":"Pigment Cel Melanoma Res."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-012-1031-3","article-title":"Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations","volume":"124","author":"Liu","year":"2012","journal-title":"Acta Neuropathol."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/bjd.15836","article-title":"KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas","volume":"177","author":"Dias-Santagata","year":"2017","journal-title":"Br J Dermatol."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1038\/s41598-020-62293-4","article-title":"The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach","volume":"10","author":"Spiegelberg","year":"2020","journal-title":"Sci Rep."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-018-0414-1","article-title":"KIT as an oncogenic driver in melanoma: an update on clinical development","volume":"20","author":"Meng","year":"2019","journal-title":"Am J Clin Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:07:16Z","timestamp":1750100836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001759","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,29]]}}}